The follow-up of breast cancer

Seminars in Oncology

Volumn 30, Issue 3, 2003, Pages 338-348

  Emens, Leisha A ^a   Davidson, Nancy E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; CA 15-3 ANTIGEN; CA 27-29 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; SEROTONIN UPTAKE INHIBITOR; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

BREAST ADENOCARCINOMA; BREAST CANCER; BREAST METASTASIS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; COMPRESSION THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; EARLY DIAGNOSIS; EVIDENCE BASED MEDICINE; FOLLOW UP; HEALTH CARE COST; HEALTH SURVEY; HEART DISEASE; HIGH RISK POPULATION; HUMAN; LEUKEMIA; LYMPHEDEMA; MASTECTOMY; MENOPAUSAL SYNDROME; MYELODYSPLASTIC SYNDROME; PATIENT CARE; PATIENT MONITORING; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW; SOCIAL SUPPORT; SURVIVAL RATE; UTERUS CANCER;

EID: 0037792853     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0093-7754(03)00094-0     Document Type: Review

References (67)

1. American Cancer Society: Cancer Facts and Figures 2002. Atlanta, GA, American Cancer Society, 2002
2. Howe HL, Wingo PA, Thun MJ, et al: The Annual Report to the Nation on the Status of Cancer (1973-1998), Featuring Cancers With Recent Increasing Trends. J Natl Cancer Inst 93:824-842, 2001
3. Garfinkel L, Boring CC, Heath CW Jr: Changing trends: An overview of breast cancer incidence and mortality. Cancer 74:222-227, 1994
4. Ernster VL, Barclay J, Kerlikowske K, et al: Incidence and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918, 1996
5. Rosen PP, Groshen S, Siago P, et al: Prognosis in T2N0M0 stage I breast carcinoma: A 20-year follow-up study. J Clin Oncol 9:1650-1661, 1991
6. Rosen PP, Groshen S, Kinne DW, et al: Factors influencing prognosis in node-negative breast carcinoma: Analysis of 767 T1N0M0/T2N0M0 patients with long term follow up. J Clin Oncol 11:2090-2100, 1993
7. Langlands AO, Pocock SJ, Kerr GR: Long-term survival of patients with breast cancer: A study of the curability of the disease. Br Med J 286:1777-1779, 1979
8. Saphner T, Tormey DC, Gray R: Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738-2746, 1996
9. Carter CL, Allen C, Hensen DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187, 1989
10. Bijker N, Petersen JL, Duchateau L, et al: Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer trial 10853. J Clin Oncol 19:2263-2271, 2001
11. Haagensen CD, Lane N, Lattes R: Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42:737-769, 1978
12. Rosen PP, Lieberman P, Braune D: Lobular carcinoma in situ of the breast: Detailed analysis of 99 patients with an average follow up of 24 years. Am J Surg Pathol 2:225-251, 1978
13. Valagussa P, Bonadonna G, Veronesi U: Patterns of relapse and survival following radical mastectomy. Analysis of 716 consecutive patients. Cancer 41:1170-1177, 1978
14. Ries LA, Hensen DE, Harras A: Survival from breast cancer according to tumor size and nodal status. Surg Oncol Clin North Am 3:35-52, 1994
15. Kamby C, Vejborj I, Kristensen B: Stage and pattern of metastases in patients with breast cancer. Cancer 62:2226-2233, 1988
16. Leborgne F, Leborgne J, Ortega B, et al: Breast conservation treatment of early stage breast cancer: Patterns of failure. Int J Rad Oncol Biophys 15:765-775, 1995
17. Hannisdal E, Gundersen S, Kvaloy S: Follow-up of breast cancer patients stage I-II: A baseline strategy. Eur J Cancer 29:992-997, 1993
18. Tomin R, Donegan W: Screening for recurrent breast cancer: Its effectiveness and prognostic value. J Clin Oncol 5:62-67, 1987
19. Zwaveling A, Albers GH, Felthuis W, et al: An evaluation of routine follow up for detection of breast cancer recurrences. J Surg Oncol 34:194-197, 1987
20. Rutgers EJ, van Sluten EA, Kluck HM: Follow-up after primary treatment of primary breast cancer. Br J Surg 76:187-190, 1989
21. Pandya KJ, McFadden E, Kalish LA, et al: Frequency and patterns of early disease recurrence and method of detection in operable breast cancer with pathologically positive axillary lymph nodes on Eastern Cooperative Oncology Group adjuvant studies: A preliminary report. Cancer Treat Symp 2:117-122, 1983
22. Pedrazzini A, Gelber R, Isley M, et al: First repeated bone scan in the observation of patients with operable breast cancer. J Clin Oncol 4:389-394, 1986
23. Broyn T, Froyen J: Evaluation of routine follow up after surgery for breast carcinoma. Acta Chir Scand 148:401-404, 1982
24. Hatschek T, Castensen J, Fagerber G: Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial. Breast Cancer Res Treat 14:321-327, 1989
25. Strier M, Rosen H: Influence of early diagnosis on prognosis of early breast cancer. Cancer 64:1128-1131, 1989
26. Valagussa P, Tess T, Rossi A, et al: Adjuvant CMF effect on site of first recurrence, and appropriate follow-up intervals, in operable breast cancer with positive axillary nodes. Breast Cancer Res Treat 1:349-359, 1981
27. Recht A, Schnitt SJ, Connolly JL: Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma. Int J Radiat Oncol Biol Phys 16:3-9, 1989
28. Fowble B, Solin L, Shultz DJ: Breast recurrence following conservative surgery and radiation: Patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 19:833-842, 1990
29. Moore M, Kinne D: Patient selection criteria for conservation surgery versus mastectomy: Memorial Hospital experience. World J Surg 18:58-62, 1994
30. Veronesi U, Luini A, Del Vecchio M: Radiotherapy after breast conserving surgery in women with localized cancer of the breast. N Engl J Med 328:1587-1591, 1993
31. Rosenman J, Bernard S, Kober C: Local recurrences in patients with breast cancer at the North Carolina Memorial Hospital (1970-1982). Cancer 57:1421-1425, 1986
32. Ahearne PM, Leach SD, Feig BW: Invasive Breast Cancer (ed 2). Philadelphia, PA, Lippincorr Williams & Wilkins, 1998
33. Hughes LE, Courtney SP: Follow-up of patients with breast cancer. Brit Med J 290: 1229-1230, 1985
34. Early Breast Cancer Trialists Collaborative Group: Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333:1444-1451, 1995
35. Meyer JE, Munzenreider JE: Computed tomographic demonstration of internal mammary lymph-node metastasis in patients with locally recurrent breast carcinoma. Radiology 139:661, 1981
36. Villari N, Fargnoli R, Mungai R: CT evaluation of chest wall recurrences of breast cancer. Eur J Radiol 5:206-208, 1983
37. Smith TJ, Davidson NE, Schapira DV, et al: American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines. J Clin Oncol 17:1080-1082, 1999
38. Schapira DV, Urban N: A minimalist policy for breast cancer surveillance. JAMA 265:380-382, 1991
39. Mellink WA, Holland R, Hendriks JHCL: The contribution of routine follow-up mammography to an early detection of asynchronous contralateral breast cancer. Cancer 67: 1844-1848, 1991
40. Crivellari D, Price KN, Hagen M, et al: Routine tests during follow-up of patients after primary treatment for operable breast cancer. Ann Oncol 6:769-776, 1995
41. Bast RC Jr, Ravdin P, Hayes DF, et al: 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 19:1865-1878, 2001
42. Molina R, Zanon G, Vilella X, et al: Use of serial carcinoembryonic antigen and CA15-3 assays in detecting relapses in breast cancer patients. Breast Cancer Res Treat 36: 41-48, 1995
43. Jager W, Kramer S, Palapelas V, et al: Breast cancer and clinical utility of CA15-3 and CEA. Scand J Clin Lab Invest 221:87-92, 1995
44. Chan DW, Beveridge RA, Muss H, et al: Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and III disease. J Clin Oncol 15:2322-2328, 1997
45. Safi F, Kohler I, Rottinger E, et al: The value of the tumor marker CA15-3 in diagnosing and monitoring breast cancer. Cancer 68:574-582, 1991
46. Kokko R, Holli K, Hakama M: CA15-3 in the follow up of localized breast cancer: A prospective study. Eur J Cancer 38:1189-1193, 2002
47. Gion M, Mione R, Leon AE, et al: Comparison of the diagnostic accuracy of CA27-29 and CA15-3 in primary breast cancer. Clin Chem 45:630-637, 1999
48. Wickerham L, Fisher B, Cronin W, et al: The efficacy of bone scanning in the follow-up of patients with operable breast cancer. Breast Cancer Res Treat 4:303-307, 1984
49. Chaudary MM, Maisey MN, Shaw PJ: Sequential bone scans and chest radiographs in the postoperative management of early breast cancer. Br J Surg 70:517-520, 1983
50. Roselli del Turco M, Palli D, Cariddi A, et al: Intensive diagnostic follow-up after treatment of primary breast cancer - A randomized trial. National Research Council Project on Breast Cancer Follow-Up. JAMA 271:1587-1592, 1994
51. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. JAMA 271:1587-1592, 1994
52. Kauczor HU, Voges EM, Wieland-Schneider C, et al: Value of routine abdominal and lymph node sonography in the follow-up of breast cancer patients. Eur J Radiol 18:104-108, 1994
53. Wahl RL: Current Status of PET in breast cancer imaging, staging, and therapy. Semin Roentgenol 36:250-260, 2001
54. Eubank WB, Mankoff DA, Vesselle HJ, et al: Detection of locoregional and distant recurrences in breast cancer patients using FDG-PET. Radiographics 22:5-17, 2002
55. Hathaway PB, Mankoff DA, Maravilla KR, et al: Value of combined FDG-PET and MR imaging in the evaluation of suspected local-regional breast cancer: Preliminary experience. Radiology 210:807-814, 1999
56. Cook GJ, Houston S, Rubens R, et al: Detection of bone metastases in breast cancer by 18F-FDG PET: Differing metabolic activity in osteoblastic and osteolytic lesions. J Clin Oncol 16:3375-3379, 1998
57. Rojas MP, Telaro E, Russo A, et al: Follow-Up Strategies for Women Treated for Early Breast Cancer (Cochrane Review). Oxford, UK, Update Software, 2002
58. Stearns V, Hayes DF: Approach to menopausal symptoms in women with breast cancer. Curr Treat Options Oncol 3:179-190, 2002
59. Fisher B, Constantino CJ, Wickerham DL: Tamoxifen for prevention of breast cancer: Report of the National Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 90:1371-1388, 1988
60. Barakat RR, Gilewski T, Almadrones L, et al: Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy. J Clin Oncol 18:3459-3463, 2000
61. Gerber B, Krause A, Muller H, et al: Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: A prospective long-term study using transvaginal ultrasound. J Clin Oncol 18:3464-3470, 2000
62. Grunfeld E, Mant D, Yudkin P, et al: Routine follow up of breast cancer in primary care: Randomized trial. Br Med J 313:665-669, 1996
63. Grunfeld E, Mant D, Yudkin P, et al: Follow-up of breast cancer in primary care vs specialist care: Results of an economic evaluation. Br J Cancer 79:1227-1233, 1999
64. Gulliford T, Opomo M, Wilson E, et al: Popularity of less frequent follow-up for breast cancer in randomized study: Initial findings from the Hotline Study. Br Med J 314:171-177, 1997
65. Carlson RW, Anderson BO, Bensinger W, et al: NCCN Practice Guidelines for Breast Cancer. Oncology 14:33-49, 2000
66. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Follow-up after treatment for breast cancer. Can Med Assoc J 158: 565-583, 1998 (suppl 3)
67. ISource National Breast Centre: Follow-up, in Clinical Practice Guidelines for the Management of Early Breast Cancer. Woolloomooloo, NSW, NHMRC NBCC, 2001, pp 97-102